PineBridge Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,404
| Closed | -$1.71M | – | 747 |
|
|
2024
Q4 | $1.71M | Buy |
36,404
+10,889
| +43% | +$512K | 0.01% | 590 |
|
|
2024
Q3 | $1.35M | Buy |
+25,515
| New | +$1.35M | 0.01% | 601 |
|
|
2019
Q4 | – | Sell |
-10,445
| Closed | -$119K | – | 1074 |
|
|
2019
Q3 | $119K | Buy |
10,445
+3,984
| +62% | +$45.4K | ﹤0.01% | 914 |
|
|
2019
Q2 | $73K | Buy |
6,461
+504
| +8% | +$5.69K | ﹤0.01% | 849 |
|
|
2019
Q1 | $48K | Sell |
5,957
-2,381
| -29% | -$19.2K | ﹤0.01% | 926 |
|
|
2018
Q4 | $53K | Buy |
+8,338
| New | +$53K | ﹤0.01% | 957 |
|
|
2017
Q4 | – | Sell |
-6,261
| Closed | -$91K | – | 1065 |
|
|
2017
Q3 | $91K | Buy |
6,261
+169
| +3% | +$2.46K | ﹤0.01% | 963 |
|
|
2017
Q2 | $74K | Buy |
+6,092
| New | +$74K | ﹤0.01% | 975 |
|